BALTIMORE – The National Institutes of Health’s National Institute on Minority Health has awarded emocha Mobile Health a $1 million Small Business Innovation Research award to evaluate its medication adherence platform for patients with tuberculosis. Researchers at the Johns Hopkins University School of Medicine will conduct the evaluation. “We value conducting rigorous scientific research to measure the impact of our technology and are honored to be able to do so through this NIH mechanism,” said Sebastian Seiguer, CEO of emocha Mobile Health, in a statement. The award builds on a study conducted in Maryland by researchers at the Johns Hopkins University School of Medicine that found emocha’s video Directly Observed Therapy platform helped patients with tuberculosis achieve 94% medication adherence. The National Institute on Drug Abuse also recently approved emocha’s plan to begin a second phase of research to evaluate its medication adherence platform for patients receiving buprenorphine treatment for opioid use disorder in partnership with the University of Washington School of Medicine and Boston Medical Center. With the addition of this grant, emocha has been awarded more than $3 million in non-dilutive funding from the NIH since 2015.
You are here: / / NIH grant to fund medication adherence study